SCHEMBL7712415

SCHEMBL7712415

Nc1ncc(Oc2ccccc2Cl)c(=O)[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
HTT P42858 1/20 0.41
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.38
MAP4K4 O95819 1/20 0.38
XDH P47989 1/20 0.38
CXCL8 P10145 1/20 0.38
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37
RECQL P46063 1/20 0.37
TYMS P04818 1/20 0.37
LMNA P02545 2/20 0.37
MASP2 O00187 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HCAR3 P49019 1/20 0.36
HCAR2 Q8TDS4 1/20 0.36
LTA4H P09960 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5206842 0.82 MEN1 (0.53) ALDH1A1HPGDKMT2ASLC6A2SLC6A3
SCHEMBL7712418 0.82 SMN1; SMN2 (0.41) ALDH1A1HTTHPGDKMT2AMAP4K4
SCHEMBL7714251 0.82 HTT (0.50) ALDH1A1HTTHPGDSLC6A2SLC6A4
SCHEMBL5206240 0.80 NOS1 (0.45) XDHRECQLLMNAMASP2LTA4H
SCHEMBL5202998 0.77 LTA4H (0.57) ALDH1A1HPGDKMT2AXDHRECQL
SCHEMBL7714596 0.77 XDH (0.42) KMT2AXDHSLC6A2SLC6A4SLC6A3
SCHEMBL5202758 0.76 LTA4H (0.36) ALDH1A1KMT2AXDHTYMSLTA4H
SCHEMBL7708592 0.75 RHEB (0.42) KMT2AMAP4K4XDHSLC6A4PTGS1
SCHEMBL7714270 0.74 CYP1A2 (0.47) SLC6A2SLC6A4SLC6A3TYMSLMNA
SCHEMBL5206393 0.74 MEN1 (0.39) KMT2ASLC6A2SLC6A4SLC6A3PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed